plumbagin has been researched along with Cancer of Mouth in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CY; Chen, JY; Chuang, JM; Han, KF; Huang, WP; Lee, CH; Lee, TH; Lin, CL; Lin, CS; Lin, MY; Yu, CI | 1 |
| Furuhashi, A; Hayashi, T; Hosokawa, Y; Ito, K; Karnan, S; Kazaoka, Y; Konishi, H; Nakaoka, T; Ono, T; Ota, A; Yamada, Y | 1 |
2 other study(ies) available for plumbagin and Cancer of Mouth
| Article | Year |
|---|---|
Plumbagin induces the apoptosis of drug-resistant oral cancer in vitro and in vivo through ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction.
Topics: Animals; Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Stress; Mice; Mitochondria; Mouth Neoplasms; Reactive Oxygen Species; Zebrafish | 2023 |
Plumbagin suppresses tumor cell growth in oral squamous cell carcinoma cell lines.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Mouth Neoplasms; Naphthoquinones | 2015 |